Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States
New England Journal of Medicine · 2024
DOI: 10.1056/nejmp2400608 ↗Kurz gefasst
Fachartikel in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Nishant Uppal und 1 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Medicine, Brigham and Women's Hospital (N.U.), the Department of Health Care Policy and the Center for Primary Care, Harvard M…. Hauptthemen laut MEDLINE: Commerce, Private Sector, Health Care Sector. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- From the Department of Medicine, Brigham and Women's Hospital (N.U.), the Department of Health Care Policy and the Center for Primary Care, Harvard Medical School (Z.S.), and the Department of Medicine, Massachusetts Ge…
ORCID-Profile: Nishant Uppal, Zirui Song
Zitieren
APA
Uppal, N., & Song, Z. (2024). Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States. New England Journal of Medicine. https://doi.org/10.1056/nejmp2400608
Vancouver
Uppal N, Song Z. Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States. New England Journal of Medicine. 2024. doi:10.1056/nejmp2400608
BibTeX
@article{Uppal2024,
author = {Uppal, Nishant and Song, Zirui},
title = {Corporate Medicine 2.0 — Special Purpose Acquisition Companies in the United States},
journal = {New England Journal of Medicine},
year = {2024},
doi = {10.1056/nejmp2400608}
}
EUVIMED